Group structure
8 companies in 3 countries
Loading…
8 companies in 3 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1–25 of 59
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| AQUATAG25mg | 50mg · Tablet | Benzthiazide | United States | Not marketed | 1965 |
| ARESTOCAINE HYDROCHLORIDE3% · Injectable | Mepivacaine | United States | Not marketed | 1975 |
| ARESTOCAINE HYDROCHLORIDE W/ LEVONORDEFRIN0.05mg/ml; 2% · Injectable | Levonordefrin, Mepivacaine | United States | Not marketed | 1976 |
| BALNEOL-HC1% · Lotion | Hydrocortisone | United States | Not marketed | 1982 |
| BUTABARBITAL SODIUM15mg | 16.2mg | 30mg | 32.4mg | 48.6mg | 97.2mg · Tablet | Butabarbital | United States | Not marketed | 1974 |
| CIN-QUIN200mg | 300mg · Capsule | Quinidine | United States | Not marketed | |
| CIN-QUIN100mg | 200mg | 300mg · Tablet | Quinidine | United States | Not marketed | |
| CURRETAB10mg · Tablet | Medroxyprogesterone | United States | Not marketed | 1978 |
| DERMACORT0.5% | 1% · Lotion | Hydrocortisone | United States | Not marketed | |
| DEXONE 0.50.5mg · Tablet | Dexamethasone | United States | Not marketed | |
| DEXONE 0.750.75mg · Tablet | Dexamethasone | United States | Not marketed | |
| DEXONE 1.51.5mg · Tablet | Dexamethasone | United States | Not marketed | 1975 |
| DEXONE 44MG · Tablet | Dexamethasone | United States | Not marketed | |
| DUPHALAC10gm/15ml · Solution | Lactulose | United States | Not marketed | |
| ESTRAGUARD0.01% · Cream | Dienestrol | United States | Not marketed | 1975 |
| ESTRATAB0.3mg | 0.625mg | 1.25mg | 2.5mg · Tablet | Conjugated estrogens, Esterified | United States | Not marketed | 1977 |
| GYNOREST10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Dydrogesterone | United States | Not marketed | |
| HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE100mg; 50mg | 25mg; 25mg | 50mg; 50mg · Capsule | Hydralazine, Hydrochlorothiazide | United States | Not marketed | 1982 |
| LITHONATE300mg carbonate/5ml · Syrup | Lithium | United States | Not marketed | |
| LITHONATE300mg · Capsule | Lithium | United States | Not marketed | 1970 |
| LITHOTABS300mg · Tablet | Lithium | United States | Not marketed | 1972 |
| ORASONE10mg | 1mg | 20mg | 50mg | 5mg · Tablet | Prednisone | United States | Not marketed | 1974 |
| PORTALAC10gm/15ml · Solution | Lactulose | United States | Not marketed | |
| PROVAL #3325mg; 30mg · Capsule | Paracetamol, Codeine | United States | Not marketed | |
| R-P MYCIN250mg · Tablet, delayed release | Erythromycin | United States | Not marketed |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 39 | 39 | 0 | CompaniesAll medicines |
| Canada | 20 | 0 | 20 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vencidos; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Läkemedelsverket, Sweden, Läkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Report an error or request removalCorrections from the company itself are welcome.
Keep Solvay’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callWell-known pharmaceutical groups, each with all its companies.